In a recent landmark decision, Bayer AG’s subsidiary, Monsanto, was ordered by a Missouri jury to pay a staggering $1.56 billion in damages in the latest Roundup trial. The verdict, […]
Latest Roundup Trial Ends in Staggering $1.5 Billion Verdict over Cancer Claims Read More »
Suboxone, a medication used to treat opioid addiction, has been touted as a safe and effective drug since its introduction in 2002. However, recent lawsuits against the drug manufacturer, Indivior,
Suboxone Dental Decay Lawsuits: How the Drug Causes Long-Term Damage to Teeth Read More »
The U.S. Food and Drug Administration (FDA) has recently taken significant steps to enhance its oversight and regulation of the baby formula market in the wake of massive recalls and
FDA Implements Enhanced Oversight and Guidelines for Infant Formula Safety Read More »
Tepezza (teprotumumab) has emerged as a groundbreaking treatment for thyroid eye disease, offering hope to patients with this rare condition. Approved by the FDA in January 2020, Tepezza has shown
Understanding and Managing Adverse Events in Patients Treated with Tepezza Read More »
Ozempic and similar drugs have become increasingly popular for the treatment of Type 2 diabetes and weight loss. However, a new study published in the Journal of the American Medical
In recent years, there has been a significant increase in the number of product liability lawsuits related to Bard implantable port devices, commonly known as port-a-caths. Port-a-caths, manufactured by companies
Bard Implantable Port Lawsuit: A Closer Look at Port-a-Caths and Their Risks Read More »
Suboxone, a medication commonly prescribed for opioid addiction, has recently come under scrutiny for its potential to cause serious dental problems in patients. One individual, David Sorensen, recently filed a
Suboxone Lawsuit Filed Over Tooth Decay Side Effects Read More »
In the world of medical treatments, port-a-caths, also known as implantable ports or subcutaneous ports, have become a common tool for delivering medications and fluids directly into a patient’s bloodstream.
Pulmonary Embolism, Migration to the Heart Leads to Bard Infuse-A-Port Lawsuit Read More »
Earlier this week, pharmaceutical and biotechnology giant Bayer was ordered to pay $332 million in damages to a man who claimed his cancer was caused by exposure to the company’s
California Jury Awards $332 Million in Roundup Trial Over Non-Hodgkin’s Lymphoma Read More »
In a significant blow to pharmaceutical giant Bayer AG, a Philadelphia jury on Friday ordered the company to pay $175 million in damages in a trial involving their widely-used weed
Roundup Verdict: Bayer Ordered to Pay $175 Million in Latest Cancer Trial Read More »
